Business Insider talks to users and the University of Arkansas team planning a 20-patient shoulder surgery trial for summer 2027.
Recap by typeshit. Full story at Insider.
Trials show large weight loss on semaglutide, and medical attention is shifting to the health effects that come with it.
Doctors at the Kenya launch of Ozempic and Wegovy cited SELECT and FLOW trial results, while warning that long-term liver evidence is still unsettled.
A new Journal of the American Chemical Society study describes a solid-state method for finding and quantifying peptide biomarkers in diluted human serum.
36:35
Lyle McDonald digs into the claim that Lilly's experimental drug burns more energy, and says the answer won't please everyone.
ADA spokesperson Sally Cram and others say dry mouth, reflux and drinking less on GLP-1s can raise cavity and erosion risk, plus cheap fixes.
A new coroner's report connects the Australian actor's death to injecting peptides that were not approved. A serious marker for the safety debate around gray market peptides.
Loading…